Detalhe da pesquisa
1.
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma.
N Engl J Med
; 387(2): 132-147, 2022 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35660812
2.
How I treat the young patient with multiple myeloma.
Blood
; 132(11): 1114-1124, 2018 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29967130
3.
Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma.
Invest New Drugs
; 38(5): 1448-1453, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32125598
4.
Phase I/II trial of the CXCR4 inhibitor plerixafor in combination with bortezomib as a chemosensitization strategy in relapsed/refractory multiple myeloma.
Am J Hematol
; 94(11): 1244-1253, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31456261
5.
A phase 2 study of modified lenalidomide, bortezomib and dexamethasone in transplant-ineligible multiple myeloma.
Br J Haematol
; 182(2): 222-230, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29740809
6.
IgM myeloma: A multicenter retrospective study of 134 patients.
Am J Hematol
; 92(8): 746-751, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28383205
7.
Treatment of Relapsed/Refractory Multiple Myeloma.
Cancer Treat Res
; 169: 169-194, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27696263
8.
Development of extramedullary myeloma in the era of novel agents: no evidence of increased risk with lenalidomide-bortezomib combinations.
Br J Haematol
; 169(6): 843-50, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26032514
9.
Incidence and clinical features of extramedullary multiple myeloma in patients who underwent stem cell transplantation.
Br J Haematol
; 169(6): 851-8, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25833301
10.
Extramedullary Waldenström macroglobulinemia.
Am J Hematol
; 90(2): 100-4, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25349134
11.
Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease.
Nature
; 451(7179): 720-4, 2008 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-18256671
12.
Risk factors for the development of orthostatic hypotension during autologous stem cell transplant in patients with multiple myeloma.
Leuk Lymphoma
; 63(10): 2403-2412, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35699975
13.
The incidence of hydrocephalus among patients with and without spinal muscular atrophy (SMA): Results from a US electronic health records study.
Orphanet J Rare Dis
; 16(1): 207, 2021 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33962637
14.
Cyclophosphamide, bortezomib, and dexamethasone combination in waldenstrom macroglobulinemia.
Am J Hematol
; 90(6): E122-3, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25703132
15.
Effect of dimethyl fumarate on lymphocyte subsets in patients with relapsing multiple sclerosis.
Mult Scler J Exp Transl Clin
; 6(2): 2055217320918619, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32440353
16.
Melflufen plus dexamethasone in relapsed and refractory multiple myeloma (O-12-M1): a multicentre, international, open-label, phase 1-2 study.
Lancet Haematol
; 7(5): e395-e407, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32213344
17.
Matrix metalloproteinase inhibition reduces oxidative stress associated with cerebral amyloid angiopathy in vivo in transgenic mice.
J Neurochem
; 109(6): 1636-47, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19457117
18.
Detection of isolated cerebrovascular beta-amyloid with Pittsburgh compound B.
Ann Neurol
; 64(5): 587-91, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19067370
19.
The development of sarcoidosis in patients receiving daclizumab: A case series from multiple clinical trials.
Respir Med
; 149: 23-27, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30885425
20.
Efficacy and safety results from a phase 1b/2, multicenter, open-label study of oprozomib and dexamethasone in patients with relapsed and/or refractory multiple myeloma.
Leuk Res
; 83: 106172, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31229804